European Archives - Page 176 of 1586 - European Medical Journal

The History of Von Willebrand Disease

The first case of VWD was described and published in 1926 by Erik von Willebrand. Therefore, 2026 marks its centenary anniversary…

Von Willebrand Disease: 100 Years of Progress and New Horizons

The 2026 Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) placed special emphasis on the centenary…

EAHAD 2026 Interview: Ana Boban

We had the pleasure of speaking with Ana Boban, President of the European Association for Haemophilia and Allied Disorders…

Baseball, bat and glove on the grass

AbbVie to sponsor leading US baseball league

This collaboration marks the first of its kind for AbbVie and signals a massive national expansion of its ‘Striking Out Cancer’ initiative.

Heart Failure Drives Mortality After PCI

Heart failure hospitalisation was associated with a markedly increased risk of death (adjusted hazard ratio [HR]: 6.11), far exceeding that of ACS (HR: 3.22) and major bleeding (HR: 2.62).

Biomarkers May Predict Flares During RA Treatment Tapering

Trial shows clinical and molecular biomarkers can predict flare risk in rheumatoid arthritis during biologic tapering, supporting personalised treatment strategies.

CKD Severity Linked to Increased Risk of Cognitive Impairment

Greater chronic kidney disease severity, particularly proteinuria, is linked to increased risk of cognitive impairment, a large cohort study finds.

Type 1 Diabetes Tied to Threefold Increase in Dementia Risk

Adults above 50 with Type 1 diabetes are nearly three times as likely to develop incident dementia as those without. Read more.

Childhood Trauma Tied to Increased Dementia Risk

Abuse, neglect, and socioeconomic deprivation in childhood have been linked to faster ageing-related changes, including an increased risk of dementia.

Low Testosterone Tied to Extreme Prostate Cancer Progression

Patients under active surveillance for prostate cancer with low testosterone are more likely to experience ‘extreme’ disease progression, a 2026 study has found.